In addition, our analysis aggregated all tumor subtypes without stratification; given the biological heterogeneity of breast cancer, NLR’s prognostic value may differ across molecular classifications (e.g., luminal A, luminal B, HER2-enriched, triple-negative). Here, ERBB2 is linked to breast carcinoma.